Evozyne announced it raised $81 Million in an initial filing from an offering of $100 Million
09/29/23, 6:54 PM
Location
Money raised
$81 million
Industry
biotechnology research
Company Info
Location
330 n. wabash avenue
chicago, illinois, united states
Additional Info
Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.